Article info
PDFChest clinic
Opinion
The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility?
- Correspondence to Professor Malcolm R Sears, McMaster University, Firestone Institute for Respiratory Health, St. Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada; searsm{at}mcmaster.ca
Citation
The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility?
Publication history
- Received July 12, 2012
- Accepted July 13, 2012
- First published August 2, 2012.
Online issue publication
September 01, 2022
Article Versions
- Previous version (29 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions